{"id":175000,"date":"2026-05-07T18:32:10","date_gmt":"2026-05-07T18:32:10","guid":{"rendered":"https:\/\/www.europesays.com\/ro\/175000\/"},"modified":"2026-05-07T18:32:10","modified_gmt":"2026-05-07T18:32:10","slug":"pastila-minune-pentru-slabit-de-la-novo-nordisk-continua-sa-faca-furori-dupa-ce","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ro\/175000\/","title":{"rendered":"Pastila-minune pentru sl\u0103bit de la Novo Nordisk continu\u0103 s\u0103 fac\u0103 furori: Dup\u0103 ce&#8230;"},"content":{"rendered":"<p> Novo Nordisk, compania danez\u0103 care a creat una dintre cele mai cunoscute pastile de sl\u0103bit din lume, a \u00eenregistrat o cre\u015ftere a v\u00e2nz\u0103rilor cu 22% \u00een primul trimestru din 2026 fa\u0163\u0103 de aceea\u015fi perioad\u0103 a anului trecut. Ac\u0163iunile companiei daneze au urcat cu 7,5% miercuri, dup\u0103 ce cererea puternic\u0103 pentru pastila de sl\u0103bit Wegovy a determinat compania s\u0103 \u00ee\u015fi revizuiasc\u0103 pozitiv estim\u0103rile de v\u00e2nz\u0103ri \u015fi profit pentru 2026, scrie Financial Times.<\/p>\n<p> Compania, care avertizase \u00een februarie c\u0103 v\u00e2nz\u0103rile ar putea sc\u0103dea cu p\u00e2n\u0103 la 13% \u00een 2026, estimeaz\u0103 acum o contrac\u0163ie de 4 p\u00e2n\u0103 la 12%. Profitul opera\u0163ional este a\u015fteptat s\u0103 se situeze \u00een acela\u015fi interval, fa\u0163\u0103 de o prognoz\u0103 anterioar\u0103 de minus 13%.<\/p>\n<p> Wegovy, aprobat\u0103 \u00een Statele Unite \u00een decembrie 2025 \u015fi lansat\u0103 pe pia\u0163\u0103 \u00een ianuarie 2026, a generat 1,3 milioane de prescrip\u0163ii \u00een primul trimestru din 2026 \u015fi a dep\u0103\u015fit 2 milioane \u00een perioada cumulat\u0103 p\u00e2n\u0103 la 17 aprilie.<br \/>Rezultatele din T1 2026 au dep\u0103\u015fit estim\u0103rile anali\u015ftilor. Novo a raportat un profit opera\u0163ional ajustat de 5,15 mld. dolari, \u00een sc\u0103dere cu 6% fa\u0163\u0103 de T1 2025.<\/p>\n<p>Te-ar putea interesa \u0219i:<\/p>\n<p> V\u00e2nz\u0103rile nete au totalizat 15,16 mld. dolari. V\u00e2nz\u0103rile ajustate, au sc\u0103zut 4%, la 10,99 miliarde de dolari. Compania a c\u00e2\u015ftigat de asemenea 4,2 mld. dolari pe fondul \u00eencheierii unui litigiu cu guvernul american.<\/p>\n<p> \u00a0<\/p>\n<p>\t\t\t\t\t\t\tPentru alte \u0219tiri, analize, articole \u0219i informa\u021bii din business \u00een timp real urm\u0103re\u0219te Ziarul Financiar pe <a href=\"https:\/\/whatsapp.com\/channel\/0029VannM9bJZg42BhXhej1Y\" target=\"_blank\" rel=\"nofollow noopener\">WhatsApp Channels<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk, compania danez\u0103 care a creat una dintre cele mai cunoscute pastile de sl\u0103bit din lume, a&hellip;\n","protected":false},"author":2,"featured_media":175001,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[97,96,41,40,38,39],"class_list":{"0":"post-175000","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-afaceri","8":"tag-afaceri","9":"tag-business","10":"tag-ro","11":"tag-romana","12":"tag-romania","13":"tag-romanian"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ro\/116534728663326643","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/175000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/comments?post=175000"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/posts\/175000\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media\/175001"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/media?parent=175000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/categories?post=175000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ro\/wp-json\/wp\/v2\/tags?post=175000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}